InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,481.27
(
-0.03%
)
US TECH 100
19,294.40
(
0.16%
)
Dow Jones
39,185.40
(
0.05%
)
Brent Oil
84.73
(
-0.80%
)
Bitcoin
60,705.87
(
-1.47%
)
Post# of 252419
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: rkrw post# 110756

Saturday, 12/11/2010 4:57:20 PM

Saturday, December 11, 2010 4:57:20 PM

Post# of 252419

They've guided to partnering Asia and keeping the ROW. I don't know anything about the solid tumor indications.

They've guided for keeping ROW rights for ponatinib for just the AML indication or are you referring to the initial CML indication as well?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up